COVID-19 Management in the Brain and Body describes the management of patients with the novel coronavirus in their varied symptoms. Detailing this multisystem disease and the variety of organs and tissues affected, this volume features chapters on neurological systems, including brain cancer, brain embolism, and meningoencephalitis. Several systems are addressed, including conditions affecting hematological, hepatobiliary, gastrointestinal, and cardiovascular systems. Telemedicine and are also discussed. This volume is relevant for all clinicians working to ensure the best outcomes and patient care of patients with COVID-19.
- Discusses the management of multisystem symptomatology, including the effects of COVID-19 on the neurological, respiratory, hematological, hepatobiliary, gastrointestinal, and cardiovascular systems
- Includes select guidelines for clinics providing care for COVID-19 patients
- Features individual chapter introductions, and a section on case studies to provide a comprehensive primer for each topic
- Contains chapters with key facts, dictionary of terms, summary points, applications to other areas pertinent to each chapter, and policies and procedures
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Techn.
Dateigröße
ISBN-13
978-0-443-18704-9 (9780443187049)
Schweitzer Klassifikation
Section A: Introductory chapters and setting the scene1. Hand hygiene strategies2. Approved vaccines for the COVID-19 pandemic: Linking in future perspectives3. Molecular methods for SARS-CoV-2 variant detectionSection B: Management4. Systematic patient assessment for acute respiratory tract ailments (SPARTA): A simple tool to improve outcomes from COVID-195. Point of care ultrasound for coronavirus disease 2019: The multiorgan approach to COVID-196. COVID-19 in patients with inflammatory bowel diseases: Features and guidelines7. Management of COVID-19 and clinical nutrition8. The management of head and neck cancer in COVID-199. The COVID-19 pandemic: Inventory management and allocation of personal protectiveequipment10. Clinical management in the COVID-19 pandemic: Rheumatic disease11. Managing migraines during the COVID-19 pandemic: An Italian experience12. Managing acute ischemic stroke in the SARS-CoV-2 pandemic13. Impact of the coronavirus disease 2019 pandemic on patients with hypertension14. Neurosurgical trauma management during COVID-19 restrictions15. The COVID-19 pandemic and management of weight gain: Implications for obesity16. COVID-19 and the management of heart failure using telemedicineSection C: Guidelines for different treatment clinics17. Guidelines for breast imaging in the COVID-19 pandemic18. Vaccine-induced (immune) thrombotic thrombocytopenia (VITT): Diagnosis, guidelines,and reporting19. Lung cancer in the era of COVID-1920. Multisystem inflammatory syndrome in children/pediatric inflammatory multisystemsyndrome: Clinical guidelinesSection D: Impact on the respiratory system21. Ground-glass nodules in the lungs of COVID-19 patients22. Cardiothoracic imaging in patients affected by COVID-1923. Cystic fibrosis and bronchial epithelial cells in SARS-CoV-2 infection24. Biomechanics and mechanobiology of the lung parenchyma following SARS-CoV-2 infection25. Long noncoding RNA profiling in respiratory specimens from COVID-19 patients26. COVID-19 and acute pulmonary embolism27. The usefulness of the alveolar-arteriolar gradient during the COVID-19 pandemicSection E: Effects on cardiovascular and hematological systems28. Cardiac manifestations of COVID-19: An overview29. Limb ischemia and COVID-1930. Thrombosis and coagulopathy in COVID-19: A new narrative31. COVID-19 myocarditis: Features of echocardiography32. COVID-19 lockdown and impact on arrhythmias33. Cardiometabolic disease and COVID-19: A new narrative34. Postrecovery COVID-19 and interlinking diabetes and cardiovascular events35. COVID-19 patients and extracorporeal membrane oxygenation36. Sars-CoV-2 infection in different hematological patientsSection F: Effects on body systems37. Dermatological reactions associated with personal protective equipment use duringthe COVID-19 pandemic38. Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccine response39. Coinfections with COVID-19: A focus on tuberculosis (TB)40. Patients with autoimmune liver disease and the impact of Sars-COV-2 infection41. COVID-19 severity and nonalcoholic fatty liver disease42. Changes in obesity and diabetes severity during the COVID-19 pandemic at VirginiaCommonwealth University health system43. The diabetic patient and concomitant conditions rhinoorbital-cerebral mucormycosisand COVID-1944. Tissue location of SARS-CoV-2 RNA: A focus on bone and implications for skeletal health45. Linking between gastrointestinal tract effects of COVID-19 and tryptophan metabolism46. Organ damage in SARS-CoV-2 infection in children: A focus on acute kidney injury47. Obesity, COVID-19 severity, and mortality48. Upper and lower gastrointestinal symptoms and manifestations of COVID-1949. The COVID-19 survivors: Impact on skeletal muscle strengthSection G: Case studies with mini review50. A case report: COVID-19 meningoencephalitis and intracranial hemorrhage51. Case study: Oral mucosal lesions in patients with COVID-1952.
